Publications:26
About Me
Dr. Amanda Leiter is a board-certified endocrinologist. In addition to her clinical work, Dr. Leiter is an epidemiology and health services researcher focused on the interaction of endocrine diseases and cancer, with a particular interest in how diabetes and obesity impact cancer treatment outcomes. Dr. Leiter has authored numerous publications on these topics.
Dr. Leiter graduated from the Icahn School of Medicine at Mount Sinai with an MD and Master of Science in Clinical Research degree. She completed her internal medicine residency and endocrinology fellowship at the Icahn School of Medicine at Mount Sinai. She is a National Institute of Health T32 research fellow for Cancer Prevention & Control in Priority Populations and received Mount Sinai's Department of Medicine's Agena Physician Scientist Award.
Dr. Leiter is committed to providing exceptional care to patients with a variety of endocrine conditions (including thyroid, adrenal, pituitary, bone diseases, diabetes, weight management, and female hormone disorders). She has a clinical interest in the treatment of diabetes and other endocrine conditions in patients with complex medical conditions, such as cancer and organ transplant.
Language
English
Position
ADJUNCT ASSISTANT PROFESSOR | Medicine, General Internal Medicine
Clinical Focus
- Adrenal Disease
- Amenorrhea
- Gestational Diabetes
- Menopause
- Osteoporosis
- Parathyroid Disorder
- Pituitary Diseases
- Polycystic Ovary Syndrome
- Thyroid Diseases
- Type 1 Diabetes
- Type 2 Diabetes
- Weight Management
- Weight Management Assessment
Publications
Selected Publications
- Statin prescription disparities in patients with breast cancer and diabetes for primary cardiovascular disease prevention. Alicia B. Yang, Grace Mhango, Chung Yin Kong, Jenny J. Lin, Juan P. Wisnivesky, Amanda Leiter. Frontiers in Oncology
- The global burden of lung cancer: current status and future trends. Amanda Leiter, Rajwanth R. Veluswamy, Juan P. Wisnivesky. Nature Reviews Clinical Oncology
- Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors. George Mellgard, Vaibhav G. Patel, Xiaobo Zhong, Himanshu Joshi, Qian Qin, Bo Wang, Anish Parikh, Tomi Jun, Parissa Alerasool, Philip Garcia, Mahalya Gogerly-Moragoda, Amanda Leiter, Emily J. Gallagher, William K. Oh, Matthew D. Galsky, Che Kai Tsao. Journal of Cancer Research and Clinical Oncology
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Leiter did not report having any of the following types of financial relationships with industry and other outside entities during 2024 and/or 2025: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.